What We're Reading: Page 127
Industry reads hand-picked by our editors
Apr 11, 2022
-
FierceBiotech
For FDA's Robert Califf, accelerated approval redo is personal
-
Science
New generation of cancer-preventing vaccines could wipe out tumors before they form
-
Reuters
Drugmakers pledge speedier European market launches to avert stricter regulation
-
Politico
How the FDA’s food division fails to regulate health and safety hazards
Apr 08, 2022
Apr 07, 2022
Apr 06, 2022
Apr 05, 2022
-
Financial Times
Chief executives of mRNA vaccine groups earned $100mn in pandemic pay
-
Bloomberg
Merck Pressed on Overseas Profits in Senate Tax Investigation
-
The Wall Street Journal
Blackstone Plants Its Flag in Boulder, Colo., an Emerging Biotech Hub
-
Endpoints News
Chirps, chats and Clubhouses: First-time biotech founders turn to social media for advice, investors and recruitment
Apr 04, 2022
-
The Wall Street Journal
Biotech Stocks, Once Booming, Enter Bear Territory
-
STAT
NIH’s cancer chief, Ned Sharpless, to step down
-
Reuters
Pharma industry-backed fund invests in two biotech companies to treat 'superbugs'
-
The New York Times
The Latest Covid Misinformation Star Says He Invented the Vaccines